The INTENS consortium is uniquely positioned to complete this ambitious effort as we have an internationally pre-eminent, multi-disciplinary team, which possesses a combination of expertise from basic molecular biology, engineering, and surgery, combining knowledge from universities, hospitals and industry. Importantly we are one of the few groups in the world with experience, infrastructure, and track record to translate regenerative medicine solutions to patients, including true clinical translation of tissue engineered organs.
The INTENS consortium consists of a multidisciplinary group of researchers working in the following organisations:
 |
University College London (UCL) Stem Cells and Regenerative Medicine, Institute of Child Health Principal investigator and coordinator of INTENS: Prof. Paolo De Coppi European Project Manager: Silvia Gigli (left in September 2021) |
 |
Koninklijke Nederlandse Akademie Van Wetenschappen (KNAW) Hubrecht Institute for Developmental Biology and Stem Cell Research Principal investigator: Prof. Hans Clevers |
  |
Kobenhavns Universitet (UCPH) Biotech Research and Innovation Centre Principal investigator: Dr. Kim Jensen |
 |
The Francis Crick Institute Limited (FCI) Principal investigator: Dr. Vivian Li |
 |
Stemcell Technologies UK LTD (STEM) Principal investigator: Dr. Ryan Conder |
 |
Ecole Polytechnique Federale de Lausanne (EPFL) Laboratory of Stem Cell Bioenginnering Principal investigator: Prof. Matthias Lutolf |
 |
The Chancellor, Masters and Scholars of the University of Cambridge (UCAM) Department of Surgery, Cambridge Stem Cell Institute Principal investigator: Dr. Ludovic Vallier |
 |
Children’s Hospital Los Angeles (CHLA) Principal investigator: Dr. Tracy Grikscheit |
 |
The University of Edinburgh (UEDIN) MRC Centre for Regenerative Medicine Principal investigator: Prof. Clare Blackburn |